Intestinal barrier function: Molecular regulation and disease pathogenesis

被引:1291
作者
Groschwitz, Katherine R. [1 ,2 ]
Hogan, Simon P. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr,Dept Pediat,Div Allergy & Immunol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr,Dept Pediat,Div Immunobiol, Cincinnati, OH 45229 USA
基金
美国国家卫生研究院;
关键词
Intestinal epithelium; CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; ENTEROPATHOGENIC ESCHERICHIA-COLI; INFLAMMATORY-BOWEL-DISEASE; CELL-ADHESION MOLECULES; NECROSIS-FACTOR-ALPHA; ZONULA OCCLUDENS TOXIN; TIGHT JUNCTION BARRIER; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSEPITHELIAL ANTIGEN TRANSPORT; INTEGRAL MEMBRANE-PROTEIN;
D O I
10.1016/j.jaci.2009.05.038
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The intestinal epithelium is a single-cell layer that constitutes the largest and most important barrier against the external environment. It acts as a selectively permeable barrier, permitting the absorption of nutrients, electrolytes, and water while maintaining an effective defense against intraluminal toxins, antigens, and enteric flora. The epithelium maintains its selective barrier function through the formation of complex protein-protein networks that mechanically link adjacent cells and seal the intercellular space. The protein networks connecting epithelial cells form 3 adhesive complexes: desmosomes, adherens junctions, and tight junctions. These complexes consist of transmembrane proteins that interact extracellularly with adjacent cells and intracellularly with adaptor proteins that link to the cytoskeleton. Over the past decade, there has been increasing recognition of an association between disrupted intestinal barrier function and the development of autoimmune and inflammatory diseases. In this review we summarize the evolving understanding of the molecular composition and regulation of intestinal barrier function. We discuss the interactions between innate and adaptive immunity and intestinal epithelial barrier function, as well as the effect of exogenous factors on intestinal barrier function. Finally, we summarize clinical and experimental evidence demonstrating intestinal epithelial barrier dysfunction as a major factor contributing to the predisposition to inflammatory diseases, including food allergy, inflammatory bowel diseases, and celiac disease. (J Allergy Clin Immunol 2009;124:3-20.)
引用
收藏
页码:3 / 20
页数:18
相关论文
共 259 条
[1]   Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity [J].
Agarwal, R ;
D'Souza, T ;
Morin, P .
CANCER RESEARCH, 2005, 65 (16) :7378-7385
[2]   Tight junctions: Molecular architecture and function [J].
Aijaz, S ;
Balda, MS ;
Matter, K .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 248, 2006, 248 :261-298
[3]  
ANDRE C, 1987, ANN ALLERGY, V59, P127
[4]   Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin [J].
Antonetti, DA ;
Wolpert, EB ;
DeMaio, L ;
Harhaj, NS ;
Scaduto, RC .
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (04) :667-677
[5]   Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse [J].
Arrieta, M. C. ;
Madsen, K. ;
Doyle, J. ;
Meddings, J. .
GUT, 2009, 58 (01) :41-48
[6]   ADIP, a novel afadin- and α-actinin-binding protein localized at cell-cell adherens junctions [J].
Asada, M ;
Irie, K ;
Morimoto, K ;
Yamada, A ;
Ikeda, W ;
Takeuchi, M ;
Takai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :4103-4111
[7]  
AsanteKorang A, 1996, J HEART LUNG TRANSPL, V15, P415
[8]   Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions [J].
Atkinson, KJ ;
Rao, RK .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 280 (06) :G1280-G1288
[9]   Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion [J].
Babinska, A ;
Kedees, MH ;
Athar, H ;
Sobocki, T ;
Sobocka, MB ;
Ahmed, T ;
Ehrlich, YH ;
Hussain, MM ;
Kornecki, E .
THROMBOSIS AND HAEMOSTASIS, 2002, 87 (04) :712-721
[10]   Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].
Baert, FJ ;
D'Haens, GR ;
Peeters, M ;
Hiele, MI ;
Schaible, TF ;
Shealy, D ;
Geboes, K ;
Rutgeerts, PJ .
GASTROENTEROLOGY, 1999, 116 (01) :22-28